Ascendis Pharma A/S : Form 6-K - MarketScreener
6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...
Source: marketscreener.com
Stay updated with breaking news from Eyconis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...
Launch of TransCon™ PTH underway with full commercial availability in Germany and Austria; U.S. PDUFA date of May 14, 2024TransCon CNP pivotal App...